Table 2.
Univariate logistic regression analysis of XB130 expression
| Recurrence-free survival | Overall survival | |||||
|---|---|---|---|---|---|---|
|
|
||||||
| Variable | No. of patients | Median (95% CI) | P | No. of patients | Median (95% CIa) | P |
| XB130 expression | 0.0001 | 0.0001 | ||||
| Positive | 87 | 42.6 (37.7-49.3) | 87 | 43.1 (36.8-50.4) | ||
| Negative | 53 | 58.4 (51.3-62.2) | 53 | 58.9 (51.6-61.8) | ||
| Tumor size (cm) | 0.026 | 0.004 | ||||
| ≤2 | 36 | 51.8 (45.7-60.2) | 36 | 53.3 (44.6-61.4) | ||
| >2 | 104 | 56.5 (44.8-62.9) | 104 | 56.1 (44.3-63.6) | ||
| Lymph node status | 0.0001 | 0.0001 | ||||
| Negative | 68 | 51.2 (47.0-52.8) | 68 | 52.5 (47.8-53.5) | ||
| Positive | 72 | 34.4 (30.6-47.7) | 72 | 34.9 (31.2-48.2) | ||